Heart failure (HF) is a complex, heterogeneous syndrome that results from impairment of
ventricular filling or ejection of blood associated with symptoms of dyspnea, fatigue, as well …

Heart failure (HF) is a significant public health concern, affecting nearly 20 million people
worldwide, with a projected 25% increase in prevalence by 2030. 1 Concomitantly, HF …

It is estimated that half of all patients with heart failure (HF) have HF with preserved ejection
fraction (HFpEF). Yet this form of HF remains a diagnostic and therapeutic challenge …

Heart failure is a complex clinical syndrome resulting from impairment of ventricular filling or
ejection of blood associated with symptoms of dyspnea, fatigue, and peripheral and/or …

Over the past 2 decades, the syndrome of heart failure with preserved ejection fraction
(HFpEF) received a lot of attention. 1–19 However, little therapeutic progress was made. 20 …

Left ventricular ejection fraction (EF) remains the major parameter for diagnosis,
phenotyping, prognosis and treatment decisions in heart failure. The 2016 ESC heart failure …

The prevalence of heart failure (HF) and its subtype, HF with preserved ejection fraction
(HFpEF), is on the rise due to aging of the population. HFpEF is convergence of several …

Research about heart failure (HF) has made major progress in the last years. We give here
an update on the most recent findings. Landmark trials have established new treatments for …

Examining the etiology and underlying pathophysiology of heart failure (HF) is an often
neglected but important aspect of treating the condition. Identifying an underlying cause …

Despite the advancement in medicine, management of heart failure (HF), which usually
presents as a disease syndrome, has been a challenge to healthcare providers. This is …